Cite

HARVARD Citation

    Murphy, R. et al. (2019). Impact of Routine Use of CDK4/6 Inhibitor Therapy on Breast Cancer Outpatient Clinic Workload and Patient Experience. Clinical oncology. 31 (7), pp. e112-. [Online]. 
  
Back to record